Report from the Annual General Meeting of Olink Holding AB (publ) on 17 April 2023
By:
Olink Proteomics AB via
GlobeNewswire
April 17, 2023 at 16:05 PM EDT
UPPSALA, Sweden, April 17, 2023 (GLOBE NEWSWIRE) -- At the Annual General Meeting (the “AGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), on 17 April 2023 the AGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the AGM and the complete proposals, which have previously been published and are available on the Company’s website, www.olink.com. Adoption of the balance sheet and income statement, disposition regarding the Company’s results and discharge from liability The AGM resolved to dispose the Company's results in accordance with the Board of Directors’ proposal, whereby no dividend will be paid for the financial year 2022 and that the Company's available funds be capitalized in a new account. The AGM also discharged the Board Members and the CEO from liability for the financial year 2022. Remuneration to the Board of Directors and Auditor The AGM decided that remuneration to the Auditor shall be paid according to approved invoices. Election of board members The AGM resolved, in accordance with the Nomination Committee’s proposal, to re-elect Johan Pietilä Holmner as Deputy Board Member. Election of auditor Resolution on incentive program LTI I 2023 and issue of warrants and stock options LTI I 2023 consists of stock options (with warrants as hedging arrangement). Upon exercise of all warrants issued within the frame of LTI I 2023, up to 70,000 shares (with reservation for any re-calculation) may be issued, equivalent to a maximum dilution of approximately 0.06 percent of the shares and votes of the Company. Upon full exercise of the warrants, the Company’s share capital will increase with SEK 170,233.46. The calculations above have been based on the number of shares and votes in the Company as of the date of the notice. Resolution on incentive program LTI II 2023 and issue of warrants, stock options and restricted stock units LTI II 2023 consists of stock options and restricted stock units (with warrants as hedging arrangement). Upon exercise of all warrants issued within the frame of LTI II 2023, up to 910,000 shares (with reservation for any re-calculation) may be issued, equivalent to a maximum dilution of approximately 0.73 percent of the shares and votes of the Company. Upon full exercise of the warrants, the Company’s share capital will increase with SEK 2,213,035.02. The calculations above have been based on the number of shares and votes in the Company as of the date of the notice. Authorization for the Board of Directors to decide on a new issue For more information please contact: IR contact Media contact ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Stock Quote
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|